Ever Supreme Bio Technology

Established in December 2016, Ever Supreme Bio Technology (ESBT)(Stock code: 6712.TW)  is comprised of domestic and foreign professional postgraduate R&D teams and medical consultants. It is dedicated to developing new drugs for stem cells and immune cells, breaking down medical barriers, and providing innovative, effective, and accurate personalized medical services. ESBT has advanced research and development capability in cell gene manufacturing processes of both stem cells and immune cells drugs, used for diversified services such as the development of new indications and the manufacture of cell preparation products.